Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Current diagnostic nomenclature includes "atypical" eating disorders (EDs) under the term other specified feeding or eating disorder (OSFED). Previous studies suggest that individuals with OSFED have similar psychological and concurrent symptoms to individuals with "classical" EDs. Our study compared people with OSFED to those with classical EDs on indices reflecting ED pathology, concurrent psychological symptoms, personality traits, functional impairment, illness duration, and pretreatment motivation. We also compared OSFED variants characterized solely by restrictive eating behaviors (OSFED-R) to variants in which binge-eating and/or purging symptoms predominated (OSFED-B/P).

Methods: Participants were 836 treatment-seeking adults (185 AN-Restricting type [AN-R], 165 AN Binge-eating/purging type [AN-B/P], 276 BN, 104 OSFED-R, and 106 OSFED-B/P) starting outpatient ED treatment. Data were analyzed with generalized linear models.

Results: Overall, findings in individuals with OSFED were comparable to those in people with a "classical" ED diagnosis on self-reported measures of concurrent psychological symptoms, personality traits, functional impairment, illness duration, and treatment motivation. However, relative to people with AN-R, individuals with OSFED-R reported higher levels of psychological ED symptoms (p < 0.001). The OSFED-B/P group had even more ED-related psychological symptoms than did the OSFED-R group (p = 0.02), but did not differ from the AN-B/P and BN groups on any of our indices.

Discussion: Findings extend previous research, underscoring the point that OSFED syndromes have serious clinical implications, comparable to those associated with full-threshold AN and BN. Results also highlight the relevance of examining heterogeneity within the OSFED category in function of a restrictive vs. binge/purge distinction.

Download full-text PDF

Source
http://dx.doi.org/10.1002/eat.24533DOI Listing

Publication Analysis

Top Keywords

psychological symptoms
12
osfed variants
8
eating disorders
8
individuals osfed
8
concurrent psychological
8
symptoms personality
8
personality traits
8
traits functional
8
functional impairment
8
impairment illness
8

Similar Publications

Gestational trophoblastic tumors (GTTs) encompass a spectrum of neoplastic conditions, including invasive mole, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor. Invasive mole, which frequently develops following a complete hydatidiform mole, represents the most common form. A cancer diagnosis constitutes a profoundly destabilizing experience, often resulting in considerable psychological distress.

View Article and Find Full Text PDF

Perceived Chronic Stress prior to SARS-CoV-2 Infection Predicts Ongoing Symptomatic COVID-19: A Prospective Cohort Study.

Psychother Psychosom

September 2025

Division of Endocrinology and Diabetology, Department of Internal Medicine, Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.

Introduction: Understanding chronic stress as a potential risk factor for COVID-19 progression could inform public health measures and personalized preventive interventions. Therefore, we investigated the influence of chronic stress prior to SARS-CoV-2 infection on symptom persistence 1 month after COVID-19 onset.

Methods: The participants of this prospective cohort study named "StressLoC" were adults with COVID-19 who had tested positive for SARS-CoV-2 infection within the last 7 days.

View Article and Find Full Text PDF

This study aimed to evaluate the antidepressant potential of Nitazoxanide (NTZ), an antiprotozoal drug with known anti-inflammatory and neuroprotective properties, in a chronic unpredictable mild stress (CUMS)-induced mice model of depression. NTZ was administered at doses of 75, 150, and 300 mg/kg, and its effects were assessed through a series of behavioral tests, including the forced swim test, tail suspension test, actophotometer test, and social interaction test. NTZ treatment at 150 and 300 mg/kg significantly improved behavioral and biochemical outcomes, relieving depressive-like symptoms and restoring neurochemical balance.

View Article and Find Full Text PDF

Background: Persistent chemotherapy-induced alopecia (pCIA) is a distressing side effect of antineoplastic agents, imposing significant psychological burdens on cancer survivors. Despite its impact, there are no standardized guidelines for diagnosis, prevention or management.

Objective: To establish consensus-based definitions, diagnostic criteria, grading systems and management recommendations for pCIA.

View Article and Find Full Text PDF

Smartphone applications (apps) represent promising tools to overcome common barriers to treatment in individuals within the Eating Disorders (EDs) spectrum, thanks to their constant availability and cost-effectiveness. In this context, Cruz et al. (2025) conducted the first meta-analysis of randomized controlled trials (RCTs) evaluating the efficacy of app-based interventions for EDs.

View Article and Find Full Text PDF